Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 8-9, Août-Septembre 2010
Page(s) 681 - 685
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2010268-9681
Publié en ligne 15 août 2010
  1. Fuchs E. Scratching the surface of skin development. Nature 2007 ; 445 : 834-42.
  2. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005 ; 6 : 328-40.
  3. Caubet C, Jonca N, Brattsand M, et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/ hK7. J Invest Dermatol 2004 ; 122 : 1235-44.
  4. Kishibe M, Bando Y, Terayama R, et al. Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins. J Biol Chem 2007 ; 282 : 5834-41.
  5. Stefansson K, Brattsand M, Ny A, et al. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol Chem 2006 ; 387 : 761-8.
  6. Borgono CA, Michael IP, Komatsu N, et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007 ; 282 : 3640-52.
  7. Bernard D, Mehul B, Thomas-Collignon A, et al. Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called stratum corneum thiol protease as cathepsin l2. J Invest Dermatol 2003 ; 120 : 592-600.
  8. Igarashi S, Takizawa T, Yasuda Y, et al. Cathepsin D, but not cathepsin E, degrades desmosomes during epidermal desquamation. Br J Dermatol 2004 ; 151 : 355-61.
  9. Deraison C, Bonnart C, Lopez F, et al. LEKTI Fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 2007 ; 18 : 3607-19.
  10. Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res 2000 ; 1 : 87-92.
  11. Schalkwijk J, de Roo C, de Jongh GJ. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochim Biophys Acta 1991 ; 1096 : 148-54.
  12. Zeeuwen PL, van Vlijmen-Willems IM, Olthuis D, et al. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice. Hum Mol Genet 2004 ; 13 : 1069-79.
  13. Komatsu N, Takata M, Otsuki N, et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 2002 ; 118 : 436-43.
  14. Comel M. Ichtyosis linearis circumflexa. Dermatologica 1949 ; 98 : 133-6.
  15. Netherton EW. A unique case of Trichorrexis Invaginata. Arch Dermatol 1958 ; 78 : 483-7.
  16. Judge MR, Morgan G, Harper JL. A clinical and immunological study of Netherton’s syndrome. Br J Dermatol 1994 ; 131 : 615-21.
  17. Chavanas S, C Bodemer, A Rochat, et al., Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000 ; 25 : 141-2.
  18. Bitoun E, Chavanas S, Irvine AD, et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 2002 ; 118 : 352-61.
  19. Bitoun E, Micheloni A, Lamant L, et al., LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 2003 ; 12 : 2417-30.
  20. Descargues P, Deraison C, Bonnart C, et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005 ; 37 : 56-65.
  21. Bonnart C, Deraison C, Lacroix M, et al. Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 2010 ; 120 : 871-82.
  22. Swartzendruber DC, Wertz PW, Kitko DJ, et al. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol 1989 ; 92 : 251-7.
  23. Sandilands A, Sutherland C, Irvine AD, et al. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009 ; 122 : 1285-94.
  24. Descargues P, Deraison C, Bonnart C, Hovnanian A. Syndrome de Netherton : un modèle d’étude de la régulation de la desquamation. Med Sci (Paris) 2005 ; 21 : 457-8.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.